Lv0
0 积分 2024-02-20 加入
Effectiveness of Six International Guidelines Using Fibrosis-4 and FibroScan for Risk Stratification of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 2 Diabetes
9小时前
已完结
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population
1天前
已完结
High inherited risk predicts age-associated increases in fibrosis in patients with MASLD
13天前
已完结
Safety and pharmacokinetics of FCN-437c, a novel cyclin-dependent kinase 4/6 inhibitor, in Chinese patients with hepatic impairment
2个月前
已完结
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
6个月前
已完结
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
7个月前
已完结
Disparities in screening and risk stratification for hispanic adults with metabolic dysfunction-associated steatotic liver disease
7个月前
已完结
Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging
8个月前
已完结
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
8个月前
已完结
Single cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity
1年前
已完结
皖公网安备34019202002308
